Skip to main content
Clinical Trials/NCT02441413
NCT02441413
Completed
Not Applicable

Transplant Optimization Using Functional Imaging (TROFI)

FLUIDDA nv1 site in 1 country3 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bronchiolitis Obliterans
Sponsor
FLUIDDA nv
Enrollment
3
Locations
1
Primary Endpoint
Airway Resistance (iRaw) using FRI
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The objective of this study is to detect Bronchiolitis Obliterans Syndrome (BOS) in an early stage using the outcome parameters generated by Functional Respiratory Imaging (FRI). Robust and automated segmentation algorithms will be developed for these parameters, focusing on quantitative computed tomography (CT) image analyses to provide the physician a more sensitive diagnostics tool. The evolution of BOS over time will be monitored using nmon-rigid image registration methods.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
November 8, 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
FLUIDDA nv
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female patient ≥ 18 years old
  • Written informed consent obtained
  • Patient who had undergone a lung transplant a year ago or more
  • Female patient of childbearing potential who confirm that a contraception method was used at least 14 days before screening visit and will continue to use a contraception method during the study
  • The patient must be able to perform the lung monitoring at home
  • Patients diagnosed with BOS 0, BOS 0-p or BOS 1

Exclusion Criteria

  • Pregnant or lactating female
  • Known history of or active airways or anastomotic complications requiring intervention such as stenting or dilation

Outcomes

Primary Outcomes

Airway Resistance (iRaw) using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Specific Airway Volume (siVaw) using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Airway Volume (iVaw) using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Lobe Volumes (iVlobes) using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Air Trapping using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Specific Airway Resistance (siRaw) using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Blood Vessel Density or Fibrosis Score using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Airway Wall Thickness using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Internal Lobar Airflow Distribution using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Low attenuation or Emphysema Score using FRI

Time Frame: 12 months

Exploratory imaging endpoints: HRCT scan will be taken at visit 1- visit 5.

Study Sites (1)

Loading locations...

Similar Trials